DLH Q3 Revenue Craters 47%, Net Loss Swells to $16.8M as Liquidity Dries Up
DLHC is trading near its 52-week low of $5.03 (7.4% above the low) on light trading volume (0.1× avg).
Summary
DLH Holdings reported a catastrophic fiscal Q3 with revenue down 47% YoY, a $16.8M net loss, and dangerously low liquidity, raising serious going-concern questions.
Updates
· Reuters — Revenue missed the lone analyst's $50 million estimate. Management expects Q4 revenue to come entirely from technology-powered solutions and sees Adjusted EBITDA margins holding near Q3 levels.
Key Events · Earnings and Guidance · DLHC
-
Revenue Collapses 47%
Q3 FY2026 revenue was $44.2M, down from $83.3M a year ago, driven by the loss of VA CMOP pharmacy contracts that transitioned to small-business prime contractors.
-
Net Loss of $16.8M
The company posted a $16.8M net loss, or $1.16 per share, compared to a $0.3M profit last year. The loss includes a $10.4M non-cash valuation allowance against deferred tax assets, reflecting management's assessment that future profitability is uncertain.
-
Liquidity Near Breaking Point
Cash on hand was just $235,000 at quarter-end, with only $5.0M in unused revolver capacity. The company has $128.7M in total debt obligations, with $21.4M classified as current.
-
Backlog Shrinks 21%
Total backlog fell to $408.5M from $514.3M at fiscal year-end, and funded backlog dropped to $66.7M from $114.1M, signaling further revenue declines ahead.
Analysis · DLHC · Trade & Services
DLH's fiscal third quarter was a disaster. Revenue fell 47% year-over-year to $44.2 million as key VA pharmacy contracts transitioned to small-business prime contractors, and the company swung to a $16.8 million net loss. The loss was inflated by a $10.4 million non-cash valuation allowance against deferred tax assets, signaling management's own doubt about near-term profitability. Cash is down to $235,000, and the revolver has only $5 million left. Backlog shrank 21% from year-end, and the market-cap decline triggered a goodwill impairment test — though no charge was taken, the risk is now explicit. This follows a June covenant amendment and a CEO departure, painting a picture of a company fighting for survival.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DLHC was trading at $5.40 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $78.3M. The 52-week trading range was $5.03 to $8.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.